Work

Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast Cancer

Year: 2005

Type: article

Source: Cancer Investigation

DOI: 10.1080/07357900500201301

Authors: Shanu Modi, Michael P. DiGiovanna, Zhao Lu, Chaya Moskowitz, Katherine S. Panageas, Catherine Van Poznak, Clifford A. Hudis, Larry Norton, Lee Tan, David F. Stern, Darryl Carter, Andrew D. Seidman

Institutions: Memorial Sloan Kettering Cancer Center, Yale University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1254123142, Transformation by the NEU Oncogene Product and EGF

OpenAlex ID: W2129377268

FWCI: 2.031

Cites: 15

Cited by: 37

Related to: 10